KR910005847B1 - 수용성 리팜피신 유도체의 제조방법 - Google Patents

수용성 리팜피신 유도체의 제조방법 Download PDF

Info

Publication number
KR910005847B1
KR910005847B1 KR1019840003836A KR840003836A KR910005847B1 KR 910005847 B1 KR910005847 B1 KR 910005847B1 KR 1019840003836 A KR1019840003836 A KR 1019840003836A KR 840003836 A KR840003836 A KR 840003836A KR 910005847 B1 KR910005847 B1 KR 910005847B1
Authority
KR
South Korea
Prior art keywords
compound
methyl
formula
rifampicin
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019840003836A
Other languages
English (en)
Korean (ko)
Other versions
KR850001207A (ko
Inventor
말라바트바 아드리아노
페라리 피에트로
카바예리 브루노
Original Assignee
그투포 레페티트 에스. 피. 에이.
레나토 스가트비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 그투포 레페티트 에스. 피. 에이., 레나토 스가트비 filed Critical 그투포 레페티트 에스. 피. 에이.
Publication of KR850001207A publication Critical patent/KR850001207A/ko
Application granted granted Critical
Publication of KR910005847B1 publication Critical patent/KR910005847B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1019840003836A 1983-07-04 1984-07-03 수용성 리팜피신 유도체의 제조방법 Expired KR910005847B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8318072 1983-07-04
GB838318072A GB8318072D0 (en) 1983-07-04 1983-07-04 Water-soluble rifampicin derivatives

Publications (2)

Publication Number Publication Date
KR850001207A KR850001207A (ko) 1985-03-16
KR910005847B1 true KR910005847B1 (ko) 1991-08-05

Family

ID=10545208

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840003836A Expired KR910005847B1 (ko) 1983-07-04 1984-07-03 수용성 리팜피신 유도체의 제조방법

Country Status (17)

Country Link
US (1) US4585589A (enExample)
EP (1) EP0133887B1 (enExample)
JP (1) JPS6036490A (enExample)
KR (1) KR910005847B1 (enExample)
AT (1) ATE29136T1 (enExample)
AU (1) AU558707B2 (enExample)
CA (1) CA1212670A (enExample)
DE (1) DE3465597D1 (enExample)
DK (1) DK157875C (enExample)
ES (1) ES8601949A1 (enExample)
GB (1) GB8318072D0 (enExample)
HU (1) HU190576B (enExample)
IE (1) IE57930B1 (enExample)
IL (1) IL72234A (enExample)
NZ (1) NZ208757A (enExample)
PH (1) PH20342A (enExample)
ZA (1) ZA844661B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8408924D0 (en) * 1984-04-06 1984-05-16 Dobfar Spa 3-azinomethyl rifamycins
KR890701591A (ko) * 1987-09-25 1989-12-21 베르너 발데그 4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체
US5180718A (en) * 1989-03-02 1993-01-19 Ciba-Geigy Corporation Acyl derivatives of oxazolorifamycins
WO1998021956A1 (en) * 1996-11-19 1998-05-28 Georgetown University Heregulin antagonists and methods for their use
EP1453837A4 (en) * 2001-11-21 2007-11-07 Activbiotics Inc TARGETED THERAPEUTIC AGENTS AND USES THEREOF
US7137963B2 (en) * 2002-08-26 2006-11-21 Flowcardia, Inc. Ultrasound catheter for disrupting blood vessel obstructions
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
WO2015157512A1 (en) * 2014-04-11 2015-10-15 Drexel University Novel methods and kits for detecting a rifamycin, or derivative or analogue thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (enExample) * 1964-07-31
GB1159267A (en) * 1966-11-03 1969-07-23 Lepetit Spa Rifamycin Derivatives
US3542762A (en) * 1967-06-07 1970-11-24 Lepetit Spa Process for rifamycins
AR207763A1 (es) * 1973-07-25 1976-10-29 Archifar Ind Chim Trentino Metodo para la preparacion de 1,3-oxacino(5,6-c)rifamicinas
GB1594134A (en) * 1977-11-25 1981-07-30 Holco Investment Inc Rifamycins
US4298692A (en) * 1979-01-25 1981-11-03 Ciba-Geigy Corporation Fermentation process for producing a rifamycin derivative
US4411896A (en) * 1981-06-03 1983-10-25 Ciba-Geigy Corporation Rifamycins, their compositions and use as antibiotics

Also Published As

Publication number Publication date
ES533957A0 (es) 1985-11-01
DK157875C (da) 1990-08-20
PH20342A (en) 1986-12-04
ES8601949A1 (es) 1985-11-01
IL72234A (en) 1987-09-16
JPS6036490A (ja) 1985-02-25
JPH0544467B2 (enExample) 1993-07-06
HUT36128A (en) 1985-08-28
DK311484A (da) 1985-01-05
DE3465597D1 (en) 1987-10-01
GB8318072D0 (en) 1983-08-03
IL72234A0 (en) 1984-10-31
IE57930B1 (en) 1993-05-19
IE841693L (en) 1985-01-04
KR850001207A (ko) 1985-03-16
DK157875B (da) 1990-02-26
CA1212670A (en) 1986-10-14
ATE29136T1 (de) 1987-09-15
AU558707B2 (en) 1987-02-05
DK311484D0 (da) 1984-06-26
EP0133887B1 (en) 1987-08-26
EP0133887A1 (en) 1985-03-13
ZA844661B (en) 1985-04-24
NZ208757A (en) 1987-08-31
US4585589A (en) 1986-04-29
AU2941184A (en) 1985-01-10
HU190576B (en) 1986-09-29

Similar Documents

Publication Publication Date Title
EP0354583B1 (en) DC-88A derivatives
US5880131A (en) High molecular weight polymer-based prodrugs
Garzon-Aburbeh et al. 1, 3-dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent
HU197295B (en) Process for production of new derivatives of n-/2'-aminphenil/-benzamid and medical preparatives containing those as active substance
KR910005847B1 (ko) 수용성 리팜피신 유도체의 제조방법
US6057303A (en) Highly lipophilic Camptothecin derivatives
WO1991016337A1 (fr) Derive de glutathion a substitution-s-(acide gras inferieur)
EP0070024A1 (en) The crystalline anhydrous form of (3S-(3 alpha(z),4 beta))-3-(((2-amino-4-thiazolyl)(1-carboxy-1-methylethoxy)-imino)-acetyl)-amino)-4-methyl-2-oxo-1-azetidinesulfonic acid, method for its preparation, mixture and pharmaceutical composition containing it
EP0178980B1 (fr) Dérivés de céphalosporines, procédé d'obtention et leur application à titre d'antibiotiques
EP0096870B1 (en) Ester of metronidazole with n,n-dimethylglycine and acid addition salt thereof
KR0178956B1 (ko) 항균성 페넴 에스테르 유도체
IE59251B1 (en) Use of spergualin derivatives for the preparation of medicaments having immunosuppressive activity
US4831038A (en) Vinblastine derivatives and pharmaceutical composition containing them
FR2567887A1 (fr) Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
KR20000010894A (ko) 탁센유도체들과 그 제조방법 및 이들을 함유한 제제
AU697856B2 (en) Brefeldin A derivatives and their utility in the treatment of cancer
US4285960A (en) Penicillin compositions
AU600536B2 (en) Crystalline salts of {3s(z)}-2-{{{1-(2-amino-4-thiazolyl) -2-{{2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl}-amino-2- oxoethylidene}-amino}oxy}acetic acid
KR930007263B1 (ko) 세프-3-엠-4-카르복실산 유도체의 제조방법
FR2952M (enExample)
EP1385858A1 (fr) Nouveaux derives 5-thio-ss-d-xylopyranosides, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique
EP0269512B1 (fr) Dérivés des céphalosporines à pharmacocinétique améliorée, procédé pour leur préparation et compositions pharmaceutiques les contenant
KR970004044B1 (ko) 약물동력학적으로 개선된 세팔로스포린 유도체, 그의 제조방법, 그를 함유하는 약제학적 조성물 및 합성 중간체
US5137917A (en) Spergualin-related compound and use thereof
JPH0228189A (ja) アスコルビン酸リン酸エステル誘導体およびその製造法

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19940806

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19940806

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000